B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
基本信息
- 批准号:10683443
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-10 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Abnormal CellAccelerationAcuteAddressAffectAffinityAntibodiesAntibody ResponseAntigensAreaAutoimmune DiseasesAutoimmunityB lymphoid malignancyB-Cell ActivationB-Cell Antigen ReceptorB-LymphocytesBasic ScienceCell CompartmentationCell physiologyCellsCellular biologyChronicClinicalClinical ResearchCollaborationsColoradoCommunicable DiseasesDevelopmentDiseaseEducational workshopEnvironmentFosteringGenerationsHIV InfectionsHIV vaccineHealthHumanImmuneImmunityIndividualInflammationInternationalIntrinsic factorKnowledgeLearningMalignant NeoplasmsMature B-LymphocyteMediatorMentorsMethodologyOutcomeParticipantPharmaceutical PreparationsPlayProductivityPublishingResearchResearch PersonnelRoleScienceScientistSignal TransductionVariantantigen-specific T cellscancer cellclinical practiceclinical translationdesignimmunoprophylaxisimprovedknowledge translationmultidisciplinarynext generationpathogenpostersprogramsprospectivepublic health prioritiesrecurrent infectionresponsesymposiumsystemic autoimmunityvaccine development
项目摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled B Cell Biology in the Context of Infectious
Diseases, Autoimmunity and B Cell Cancers, organized by Drs. Susan Pierce and Facundo Batista. The
conference will be held in Keystone, Colorado from June 6 - 10, 2023.
Effective B cell antibody responses are essential for human health and protection against deadly infectious
diseases. However, B cell antibodies are also mediators of devastating autoimmune diseases, and, when
released from normal control mechanisms, B cell malignancies are common; and many remain untreatable. It
is also becoming evident that the mature B cell compartment is highly heterogeneous and that antigen-driven
fates of individual B cells are dependent on several factors, including the affinity of the B cell receptor (BCR)
and how the BCR is wired to the B cell’s activation machinery, along with the quality of the immune
environment as defined by both antigen-specific T cells and innate immune cells responding to pathogen-
derived signals. The generation of long-lived protective immunity versus B cell malignancies, or systemic
autoimmunity, may represent the spectrum of outcomes resulting from variations in and interactions between
these intrinsic factors and the surrounding context. If so, our ability to rationally manipulate B cell responses to
develop vaccines against infectious diseases, as well as therapies for autoimmune diseases and B cell
cancers, may be greatly accelerated by a detailed understanding of the fundamentals of B cell biology. The
translation of this knowledge to clinical and basic research will allow the field to address the most pressing
public health priorities of our times, ranging from acute and chronic infectious diseases to autoimmunity and B
cell malignancies. Finally, this conference is being held jointly with the Keystone Symposia conference, HIV
Vaccines, Immunoprophylaxis and Drugs. This pairing is ideal to discuss how B cell abnormalities contribute
to HIV infection, especially in terms of the potential for antibody-based vaccine development. Participants from
both conferences will have the opportunity to network through shared sessions, mealtimes, and evening poster
sessions.
摘要
请求支持一个题为“传染病背景下的B细胞生物学”的基石研讨会。
疾病,自身免疫和B细胞癌症,由苏珊皮尔斯和法昆多巴蒂斯塔博士组织。的
会议将于2023年6月6日至10日在科罗拉多的Keystone举行。
有效的B细胞抗体应答对于人类健康和保护免受致命的传染性疾病是必不可少的。
疾病然而,B细胞抗体也是破坏性自身免疫性疾病的介质,并且,当
B细胞恶性肿瘤从正常控制机制中释放出来是常见的,并且许多仍然无法治疗。它
成熟B细胞区室是高度异质的,
单个B细胞的命运取决于几个因素,包括B细胞受体(BCR)的亲和力
以及BCR如何与B细胞的激活机制相连,沿着免疫的质量
由抗原特异性T细胞和应答病原体的先天免疫细胞两者定义的环境-
衍生信号。产生针对B细胞恶性肿瘤或系统性
自身免疫性,可能代表的结果的频谱所造成的变化和相互作用之间
这些内在因素和周围环境。如果是这样的话,我们理性地操纵B细胞对
开发针对传染病的疫苗,以及针对自身免疫性疾病和B细胞
对B细胞生物学基本原理的详细了解可能会大大加快癌症的发生。的
将这些知识转化为临床和基础研究将使该领域能够解决最紧迫的问题,
我们这个时代的公共卫生优先事项,从急性和慢性传染病到自身免疫和B
细胞恶性肿瘤最后,这次会议将与艾滋病毒/艾滋病问题基石专题讨论会会议联合举行。
疫苗、免疫预防和药物。这种配对是理想的讨论如何B细胞异常有助于
艾滋病毒感染,特别是在抗体为基础的疫苗开发的潜力。的与会者
这两个会议将有机会通过共享会议、用餐时间和晚上的海报进行联网
sessions.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERRY L. SHEPPARD其他文献
TERRY L. SHEPPARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERRY L. SHEPPARD', 18)}}的其他基金
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
肺动脉高压:最新技术和治疗机会
- 批准号:
10682118 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
妊娠期感染:致病机制、实验进展和临床策略
- 批准号:
10540260 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
微生物群-免疫相互作用的机制-迈向下一个十年
- 批准号:
10753451 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Transposable Elements at the Crossroads of Evolution, Health and Disease
处于进化、健康和疾病十字路口的转座元件
- 批准号:
10750852 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
长期新冠肺炎和 SARS CoV 2 (PASC) 急性后遗症:发病机制和治疗
- 批准号:
10749522 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Inflammation in the Lung: Friend or Foe in Viral Infections?
肺部炎症:病毒感染的朋友还是敌人?
- 批准号:
10681956 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
B 细胞和三级淋巴结构:癌症治疗的新兴靶点
- 批准号:
10754008 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Standard Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Continuing Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)